RetinalGenix Technologies Inc. financial data

Symbol
RTGN on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
1450 North Mcdowell Boulevard, Suite 150, Petaluma, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 18, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity -103 % -3.24%
Return On Equity 243 % +48%
Return On Assets -7.05K % +91.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.1M shares +2.85%
Common Stock, Shares, Outstanding 18.1M shares +2.68%
Entity Public Float 15.5M USD +13.5%
Common Stock, Value, Issued 1.81K USD -0.44%
Weighted Average Number of Shares Outstanding, Basic 18M shares +4.02%
Weighted Average Number of Shares Outstanding, Diluted 18M shares +4.02%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 153K USD +12.7%
General and Administrative Expense 1.35M USD +75.8%
Costs and Expenses 21.7K USD
Net Income (Loss) Attributable to Parent -4M USD -79.6%
Earnings Per Share, Basic -0.23 USD/shares -64.3%
Earnings Per Share, Diluted -0.23 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 44 USD -98.8%
Assets, Current 79.1K USD +179648%
Property, Plant and Equipment, Net 81 USD -55.2%
Operating Lease, Right-of-Use Asset 7.69K USD
Assets 88.9K USD +39391%
Accounts Payable, Current 340K USD
Liabilities, Current 1.94M USD
Operating Lease, Liability, Noncurrent 7.03K USD
Liabilities 1.94M USD +79.5%
Retained Earnings (Accumulated Deficit) -14.6M USD -37.8%
Stockholders' Equity Attributable to Parent -1.85M USD -71.3%
Liabilities and Equity 88.9K USD +39391%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -143K USD -84.2%
Net Cash Provided by (Used in) Financing Activities 193K USD +127%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 18.1M shares +2.68%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 50.4K USD +578%
Operating Lease, Liability 7.69K USD
Depreciation 25 USD 0%
Lessee, Operating Lease, Liability, to be Paid 24.1K USD
Operating Lease, Liability, Current 662 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.11K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 7.88K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16.4K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.52K USD
Deferred Tax Assets, Operating Loss Carryforwards 1.65M USD +20.3%
Preferred Stock, Shares Authorized 40M shares 0%
Additional Paid in Capital 12.7M USD +34%
Deferred Tax Assets, Net of Valuation Allowance 3.32M USD +23.3%
Interest Expense 3.84K USD -17.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%